Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Germline variants drive myelodysplastic syndrome in young adults
Simone Feurstein, Jane E. Churpek, Tom Walsh, et al.
Leukemia (2021) Vol. 35, Iss. 8, pp. 2439-2444
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2228-2247
Open Access | Times Cited: 143
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages
Simone Feurstein, Amy M. Trottier, Noel Estrada‐Merly, et al.
Blood (2022) Vol. 140, Iss. 24, pp. 2533-2548
Open Access | Times Cited: 69
Approach to the diagnosis of aplastic anemia
Amy E. DeZern, Jane E. Churpek
Blood Advances (2021) Vol. 5, Iss. 12, pp. 2660-2671
Open Access | Times Cited: 61
Diagnosis and classification of myelodysplastic syndromes
Robert P. Hasserjian, Ulrich Germing, Luca Malcovati
Blood (2023) Vol. 142, Iss. 26, pp. 2247-2257
Closed Access | Times Cited: 24
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
Deepak Singhal, Christopher N Hahn, Simone Feurstein, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3245-3256
Open Access | Times Cited: 44
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
Caner Saygin, Gregory W. Roloff, Christopher N Hahn, et al.
Blood Advances (2022) Vol. 7, Iss. 4, pp. 549-554
Open Access | Times Cited: 33
Novel precision medicine approaches and treatment strategies in hematological malignancies
Richard Rosenquist, Elsa Bernard, Tom Erkers, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 413-436
Open Access | Times Cited: 19
Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges
Kiran Tawana, Anna Brown, Jane E. Churpek
British Journal of Haematology (2021) Vol. 196, Iss. 6, pp. 1293-1310
Open Access | Times Cited: 40
Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity
Elisabetta Molteni, Elisa Bono, Anna Gallí, et al.
Blood (2023) Vol. 142, Iss. 7, pp. 643-657
Open Access | Times Cited: 14
Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene–Environment Interactions
César Cobaleda, Lucy A. Godley, Kim E. Nichols, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 396-405
Open Access | Times Cited: 5
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
Blood Reviews (2023) Vol. 60, pp. 101072-101072
Closed Access | Times Cited: 12
Myelodysplastic syndromes: new methods of diagnosis, prognostication, and treatment
Kathrin Nachtkamp, Guido Kobbe, Norbert Gattermann, et al.
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 11
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
Amy M. Trottier, Simone Feurstein, Lucy A. Godley
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 1, pp. 101537-101537
Closed Access | Times Cited: 4
Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in RUNX1 -familial platelet disorder
Mona Mohammadhosseini, Trevor Enright, Adam DuVall, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 780
Closed Access
Germline predisposition to hematopoietic malignancies
Simone Feurstein, Michael W. Drazer, Lucy A. Godley
Human Molecular Genetics (2021) Vol. 30, Iss. R2, pp. R225-R235
Open Access | Times Cited: 25
Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies
Serine Avagyan, Akiko Shimamura
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution
Francesco Baccelli, Davide Leardini, Sara Cerasi, et al.
Annals of Hematology (2023) Vol. 102, Iss. 4, pp. 699-705
Open Access | Times Cited: 10
Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children
Oded Gilad, Orly Dgany, Sharon Noy‐Lotan, et al.
Haematologica (2022) Vol. 107, Iss. 9, pp. 2081-2095
Open Access | Times Cited: 16
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia
Yasuo Kubota, Misam Zawit, Jibran Durrani, et al.
Leukemia (2022) Vol. 36, Iss. 12, pp. 2827-2834
Closed Access | Times Cited: 15
Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications
Lucy A. Godley, Courtney D. DiNardo, Kelly L. Bolton
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 2
Importance of genetic clarification in cytopenia syndromes (childhood myelodysplastic syndrome forms)
Wolfgang Novak, Doris Kroiss, Susanne Karlhuber, et al.
memo - Magazine of European Medical Oncology (2024) Vol. 17, Iss. 4, pp. 297-301
Open Access | Times Cited: 2
Genetics of Myelodysplastic Syndromes
Caner Saygin, Lucy A. Godley
Cancers (2021) Vol. 13, Iss. 14, pp. 3380-3380
Open Access | Times Cited: 14
Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment
Fabiana Kalina Marques, Adriano de Paula Sabino
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113905-113905
Open Access | Times Cited: 9
Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle
Simone Feurstein
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)
Josephine Anne Lucero, Salman Al-Harbi, Karen Yee
Current Oncology (2023) Vol. 30, Iss. 7, pp. 6177-6196
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top